Takara Bio Inc. announced unaudited consolidated earnings results for the year ended March 31, 2020. For the year, the company reported net sales of JPY 34,565 million against JPY 35,841 million a year ago. Operating profit was JPY 6,274 million against JPY 5,463 million a year ago. Net income attributable to the owners of the parent was JPY 6,347 million against JPY 5,665 million a year ago. Net income per share was JPY 31.72 against JPY 30.38 a year ago.

For the six months ending September 30, 2020, the company expects net sales of JPY 14,365 million, operating profit of JPY 619 million.

For the year ending March 31, 2021, the company expects net sales of JPY 33,800 million, operating profit of JPY 4,500 million, net income attributable to the owners of the parent of JPY 2,600 million and net income per share of JPY 21.59 per share.